Authors: Gaston Slullitel, Yasuhito Tanaka, Ryan Rogero, Valeria Lopez, Eiichiro Iwata, Yusuke Yamamoto
RECOMMENDATION: Though one study supporting topically-applied vancomycin has shown it to reduce the rate of deep infection in diabetic patients undergoing foot and ankle surgery, there is insufficient evidence to show benefits or to show any risks associated with the use of vancomycin powder during TAA or other foot and ankle procedures in a general population.
LEVEL OF EVIDENCE: Consensus
DELEGATE VOTE: Agree: 100%, Disagree: 0%, Abstain: 0% (Unanimous, Strongest Consensus)